Search for: "State v. Bartlett" Results 1 - 20 of 448
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jul 2013, 5:00 am by Bexis
  The subject is preemption – specifically the the United States Supreme Court’s recent ruling in Mutual Pharmaceutical Company, Inc. v. [read post]
19 Mar 2013, 6:58 am by Bexis
Bartlett – that is to say Mutual Pharmacy Co. v. [read post]
2 May 2012, 1:27 pm by Bexis
The First Circuit decided Bartlett v. v. [read post]
23 Jul 2010, 7:28 am by Bexis
Last Friday we had a brief post about the new decision in Bartlett v. [read post]
2 Jun 2015, 9:53 am by Matthew L.M. Fletcher
Here: State of Nebraska v Parker cert petition Questions presented: In Solem v. [read post]
30 Nov 2012, 2:00 pm by Bexis
Bartlett, that a state court plaintiff can argue that an FDA approved drug should be removed from the market altogether. [read post]
5 Jul 2013, 7:01 am by FDABlog HPM
Bartlett (Docket No. 12-0142) on June 24th, ruling that state-law design-defect claims that turn on the adequacy of a drug’s warnings are preempted by the FDC Act and under the Court’s 2011 decision in PLIVA Inc. v. [read post]
25 Jan 2013, 12:47 pm by Bexis
  We’ve received the same bone-headed response from an appellate court in a branded case, seeWimbush v. [read post]
13 Oct 2008, 1:59 pm
The Court will explore in Bartlett v. [read post]
24 Jun 2013, 8:30 pm by constitutional lawblogger
Bartlett that the Federal Food, Drug, and Cosmetic Act, or FDCA, preempted a state-law design-defect claim against a generic drug manufacturer. [read post]